$CLDX News Stock leaders flex muscles 2:58 p.m
Post# of 88922
Posted On: 04/21/2014 9:52:58 AM
$CLDX News
Stock leaders flex muscles 2:58 p.m. Feb. 27, 2014 - The Trading Deck
S&P 500 rattles the cage on latest all-time high 12:28 p.m. Feb. 24, 2014 - Michael Ashbaugh
This tiny mutual fund is no. 1 for 2013 8:33 a.m. Jan. 7, 2014 - Suzanne McGee
Reading Wall Street’s tea leaves 3:44 p.m. Dec. 6, 2013 - The Trading Deck
Monthly jobs report triggers technical whipsaw 12:23 p.m. Sept. 6, 2013 - Michael Ashbaugh
Charting a market divergence 11:21 a.m. Aug. 22, 2013 - Michael Ashbaugh
Six stocks on the move 2:42 p.m. Aug. 21, 2013 - The Trading Deck
Charting a slow-motion test of major resistance 11:10 a.m. July 3, 2013 - Michael Ashbaugh
S&P 500 hesitates at the breakdown point 11:14 a.m. June 26, 2013 - Michael Ashbaugh
3 longs and 3 shorts to watch 3:22 p.m. June 12, 2013 - The Trading Deck
3 longs and 3 shorts to watch 2:33 p.m. April 17, 2013 - The Trading Deck
Hedge Funds have bought these stocks recently 3:04 p.m. April 12, 2013 - Insider Monkey
Hedge funds are bullish on these 5 stocks 8:38 a.m. Jan. 3, 2013 - Insider Monkey
Thursday’s top gaining and declining stocks 3:24 p.m. May 24, 2012 - MarketWatch
Friday’s biggest gaining and declining stocks 5:40 p.m. Feb. 24, 2012 - Kate Gibson
Celldex prices shares at 12% discount 12:26 p.m. Feb. 24, 2012 - MarketWatch.com
Rindopepimut ups brain cancer survival: Celdex 3:29 p.m. Nov. 21, 2011 - MarketWatch.com
Wednesday’s biggest gaining and declining stocks 3:33 p.m. May 18, 2011 - Kate Gibson
Celldex, Shire in drug-sector spotlight 1:35 p.m. May 18, 2011 - Val Brickates Kennedy
Celldex Therapeutics offer prices at 19% discount 9:48 a.m. May 18, 2011 - MarketWatch.com
Cramer's Mad Money - A Trader's Trash Is An Investor's Treasure (4/17/14) 6:08 a.m. April 18, 2014 - Seeking Alpha
Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's "Perilous Reversal" Stock 9:52 a.m. April 17, 2014 - TheStreet.com
Celldex's Phase 1 Study of CDX-1401 Published in Science Translational Medicine 1:02 p.m. April 16, 2014 - benzinga.com
Hottest Healthcare Stocks Now – QCOR IMGN LCI PCRX 8:15 a.m. April 9, 2014 - InvestorPlace.com
Encouraging Pre-Clinical Data from Celldex - Analyst Blog 5:40 p.m. April 8, 2014 - Zacks.com
A Sharp Pullback In Celldex Could Be A Window Of Opportunity 3:41 p.m. April 8, 2014 - Seeking Alpha
8 Biotech Events To Anticipate This Year: Part Two 5:04 p.m. April 7, 2014 - Seeking Alpha
Jefferies Biotech Stocks to Buy With Breakthrough Drug Innovations 7:56 a.m. April 3, 2014 - 247WallSt.com
'Mad Money' Lightning Round: I Want You to Buy Costco 6:00 a.m. April 3, 2014 - TheStreet.com
Cramer's Lightning Round - This Is The Right Level For Costco (4/2/14) 5:50 a.m. April 3, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Hope Springs Eternal 8:24 p.m. April 2, 2014 - TheStreet.com
3 Biotech Stocks Trading The Wrong Direction In March 4:58 p.m. March 28, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – EXAS CLDX CLVS HSP 1:30 p.m. March 27, 2014 - InvestorPlace.com
These Stocks Are Getting Hit Hardest During March's Biotech 'Correction' 2:35 p.m. March 25, 2014 - TheStreet.com
Mid-Afternoon Market Update: Markets Recover Slightly As Healthcare Stocks Continue to Show Weakness 2:33 p.m. March 24, 2014 - benzinga.com
Mid-Day Market Update: NASDAQ Tumbles 1.65%; Nu Skin Shares Surge After AIC China Review Update 11:48 a.m. March 24, 2014 - benzinga.com
Mid-Morning Market Update: Markets Mostly Lower; ReneSola Swings To Q4 Profit 9:35 a.m. March 24, 2014 - benzinga.com
Northwest Bio's German Smokescreen Obscures DCVax Problems 2:44 p.m. March 11, 2014 - TheStreet.com
Celldex Therapeutics Is Shutting Down CDX-1135: What Does It Mean? 3:11 p.m. March 10, 2014 - Seeking Alpha
Oppenheimer Top Stocks to Buy as Bull Market Turns Five Years Old 9:26 a.m. March 10, 2014 - 247WallSt.com
Celldex's Phase 1 Study of CDX-1401 Published in Science Translational Medicine 2:01 p.m. April 16, 2014 - GlobeNewswire
Strategic Collaborations, Preclinical Studies Results, Patient Enrollment, Earnings Release Schedule, and Clinical Trial Initiations - Analyst Notes on Pacira, Celldex, Aegerion, Furiex, and Prothena 8:00 a.m. April 14, 2014 - PR Newswire - PRF
Celldex Therapeutics Establishes Preclinical Proof of Concept for New Antibody Drug Conjugate CDX-014; Data presented at AACR 2014 4:01 p.m. April 7, 2014 - GlobeNewswire
Celldex Therapeutics to Present Antibody-Drug Conjugate CDX-014 Preclinical Proof of Concept Data at AACR 2014 8:04 a.m. April 3, 2014 - GlobeNewswire
Critical Alerts For Starbucks, Verizon Communications, Du Pont, Celldex Therapeutics, and Level 3 Communications Released By InvestorsObserver 9:31 a.m. March 26, 2014 - PR Newswire - PRF
Technical Pointers - Top Gainers: Celldex Therapeutics, Sonus Networks, YOU On Demand Holdings, and CombiMatrix 9:12 a.m. March 18, 2014 - PR Newswire - PRF
Celldex Reports Fiscal 2013 Business/Financial Results and Outlines 2014 Strategy 9:03 a.m. March 3, 2014 - GlobeNewswire
Celldex to Report Fourth Quarter and Fiscal 2013 Business/Financial Results and Host 2014 Strategy Conference Call 2:30 p.m. Feb. 25, 2014 - GlobeNewswire
Critical Alerts For AT&T, Mastercard, Disney, Du Pont, and Celldex Therapeutics Released By InvestorsObserver 10:31 a.m. Feb. 12, 2014 - PR Newswire - PRF
Celldex Announces Upcoming Presentation at the 2014 Leerink Global Healthcare Conference 12:00 p.m. Feb. 6, 2014 - GlobeNewswire
Mentor Capital Cancer Immunotherapy Index Up 97% in 2013 12:02 p.m. Jan. 21, 2014 - BusinessWire - BZX
Critical Alerts For Facebook, DirecTV, Du Pont, BIDU, and Celldex Released By InvestorsObserver 10:31 a.m. Jan. 9, 2014 - PR Newswire
Retirement Announcements, Stock Price Movements, and Scheduled Conferences Presentations - Research Report on Gilead, Aegerion, Celldex, Alnylam, and Ironwood 9:00 a.m. Jan. 9, 2014 - PR Newswire
Clinical Study Updates, Collaborations, and Stock Price Updates - Research Report on Medtronic, Regeneron, Celldex, Cubist, and MannKind 9:00 a.m. Dec. 31, 2013 - PR Newswire
Health Care Sector Technical Data: XOMA, Celldex Therapeutics, Illumina, and Immunomedics 9:12 a.m. Dec. 19, 2013 - PR Newswire
Share Price Movements and Clinical Studies - Research Report on Celldex Therapeutics, Envision, MannKind, Covance, and Auxilium 9:00 a.m. Dec. 19, 2013 - PR Newswire
Clinical Trial Results, Partnerships, and Reimbursement Rates - Research Report on Celldex, Centene, Enanta, Novartis, and BG Medicine 9:00 a.m. Dec. 13, 2013 - PR Newswire
New Clinical Trials, Pricing of Common Stock and Adjusted Conversion of Convertible Senior Notes - Research Report on Regeneron, Celldex, PDL BioPharma, Amedisys, and Exelixis 9:00 a.m. Dec. 11, 2013 - PR Newswire
Celldex's CDX-301 in Combination with Mozobil(R) Increases Hematopoietic Stem Cell Mobilization and Results in Improved Transplantation of Mobilized Cells in Preclinical Studies; Results Presented at ASH 2013 9:30 a.m. Dec. 10, 2013 - GlobeNewswire
Celldex Announces Exercise of Underwriters' Option to Purchase Additional Shares 6:03 p.m. Dec. 9, 2013 - GlobeNewswire
Stock leaders flex muscles 2:58 p.m. Feb. 27, 2014 - The Trading Deck
S&P 500 rattles the cage on latest all-time high 12:28 p.m. Feb. 24, 2014 - Michael Ashbaugh
This tiny mutual fund is no. 1 for 2013 8:33 a.m. Jan. 7, 2014 - Suzanne McGee
Reading Wall Street’s tea leaves 3:44 p.m. Dec. 6, 2013 - The Trading Deck
Monthly jobs report triggers technical whipsaw 12:23 p.m. Sept. 6, 2013 - Michael Ashbaugh
Charting a market divergence 11:21 a.m. Aug. 22, 2013 - Michael Ashbaugh
Six stocks on the move 2:42 p.m. Aug. 21, 2013 - The Trading Deck
Charting a slow-motion test of major resistance 11:10 a.m. July 3, 2013 - Michael Ashbaugh
S&P 500 hesitates at the breakdown point 11:14 a.m. June 26, 2013 - Michael Ashbaugh
3 longs and 3 shorts to watch 3:22 p.m. June 12, 2013 - The Trading Deck
3 longs and 3 shorts to watch 2:33 p.m. April 17, 2013 - The Trading Deck
Hedge Funds have bought these stocks recently 3:04 p.m. April 12, 2013 - Insider Monkey
Hedge funds are bullish on these 5 stocks 8:38 a.m. Jan. 3, 2013 - Insider Monkey
Thursday’s top gaining and declining stocks 3:24 p.m. May 24, 2012 - MarketWatch
Friday’s biggest gaining and declining stocks 5:40 p.m. Feb. 24, 2012 - Kate Gibson
Celldex prices shares at 12% discount 12:26 p.m. Feb. 24, 2012 - MarketWatch.com
Rindopepimut ups brain cancer survival: Celdex 3:29 p.m. Nov. 21, 2011 - MarketWatch.com
Wednesday’s biggest gaining and declining stocks 3:33 p.m. May 18, 2011 - Kate Gibson
Celldex, Shire in drug-sector spotlight 1:35 p.m. May 18, 2011 - Val Brickates Kennedy
Celldex Therapeutics offer prices at 19% discount 9:48 a.m. May 18, 2011 - MarketWatch.com
Cramer's Mad Money - A Trader's Trash Is An Investor's Treasure (4/17/14) 6:08 a.m. April 18, 2014 - Seeking Alpha
Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's "Perilous Reversal" Stock 9:52 a.m. April 17, 2014 - TheStreet.com
Celldex's Phase 1 Study of CDX-1401 Published in Science Translational Medicine 1:02 p.m. April 16, 2014 - benzinga.com
Hottest Healthcare Stocks Now – QCOR IMGN LCI PCRX 8:15 a.m. April 9, 2014 - InvestorPlace.com
Encouraging Pre-Clinical Data from Celldex - Analyst Blog 5:40 p.m. April 8, 2014 - Zacks.com
A Sharp Pullback In Celldex Could Be A Window Of Opportunity 3:41 p.m. April 8, 2014 - Seeking Alpha
8 Biotech Events To Anticipate This Year: Part Two 5:04 p.m. April 7, 2014 - Seeking Alpha
Jefferies Biotech Stocks to Buy With Breakthrough Drug Innovations 7:56 a.m. April 3, 2014 - 247WallSt.com
'Mad Money' Lightning Round: I Want You to Buy Costco 6:00 a.m. April 3, 2014 - TheStreet.com
Cramer's Lightning Round - This Is The Right Level For Costco (4/2/14) 5:50 a.m. April 3, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Hope Springs Eternal 8:24 p.m. April 2, 2014 - TheStreet.com
3 Biotech Stocks Trading The Wrong Direction In March 4:58 p.m. March 28, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – EXAS CLDX CLVS HSP 1:30 p.m. March 27, 2014 - InvestorPlace.com
These Stocks Are Getting Hit Hardest During March's Biotech 'Correction' 2:35 p.m. March 25, 2014 - TheStreet.com
Mid-Afternoon Market Update: Markets Recover Slightly As Healthcare Stocks Continue to Show Weakness 2:33 p.m. March 24, 2014 - benzinga.com
Mid-Day Market Update: NASDAQ Tumbles 1.65%; Nu Skin Shares Surge After AIC China Review Update 11:48 a.m. March 24, 2014 - benzinga.com
Mid-Morning Market Update: Markets Mostly Lower; ReneSola Swings To Q4 Profit 9:35 a.m. March 24, 2014 - benzinga.com
Northwest Bio's German Smokescreen Obscures DCVax Problems 2:44 p.m. March 11, 2014 - TheStreet.com
Celldex Therapeutics Is Shutting Down CDX-1135: What Does It Mean? 3:11 p.m. March 10, 2014 - Seeking Alpha
Oppenheimer Top Stocks to Buy as Bull Market Turns Five Years Old 9:26 a.m. March 10, 2014 - 247WallSt.com
Celldex's Phase 1 Study of CDX-1401 Published in Science Translational Medicine 2:01 p.m. April 16, 2014 - GlobeNewswire
Strategic Collaborations, Preclinical Studies Results, Patient Enrollment, Earnings Release Schedule, and Clinical Trial Initiations - Analyst Notes on Pacira, Celldex, Aegerion, Furiex, and Prothena 8:00 a.m. April 14, 2014 - PR Newswire - PRF
Celldex Therapeutics Establishes Preclinical Proof of Concept for New Antibody Drug Conjugate CDX-014; Data presented at AACR 2014 4:01 p.m. April 7, 2014 - GlobeNewswire
Celldex Therapeutics to Present Antibody-Drug Conjugate CDX-014 Preclinical Proof of Concept Data at AACR 2014 8:04 a.m. April 3, 2014 - GlobeNewswire
Critical Alerts For Starbucks, Verizon Communications, Du Pont, Celldex Therapeutics, and Level 3 Communications Released By InvestorsObserver 9:31 a.m. March 26, 2014 - PR Newswire - PRF
Technical Pointers - Top Gainers: Celldex Therapeutics, Sonus Networks, YOU On Demand Holdings, and CombiMatrix 9:12 a.m. March 18, 2014 - PR Newswire - PRF
Celldex Reports Fiscal 2013 Business/Financial Results and Outlines 2014 Strategy 9:03 a.m. March 3, 2014 - GlobeNewswire
Celldex to Report Fourth Quarter and Fiscal 2013 Business/Financial Results and Host 2014 Strategy Conference Call 2:30 p.m. Feb. 25, 2014 - GlobeNewswire
Critical Alerts For AT&T, Mastercard, Disney, Du Pont, and Celldex Therapeutics Released By InvestorsObserver 10:31 a.m. Feb. 12, 2014 - PR Newswire - PRF
Celldex Announces Upcoming Presentation at the 2014 Leerink Global Healthcare Conference 12:00 p.m. Feb. 6, 2014 - GlobeNewswire
Mentor Capital Cancer Immunotherapy Index Up 97% in 2013 12:02 p.m. Jan. 21, 2014 - BusinessWire - BZX
Critical Alerts For Facebook, DirecTV, Du Pont, BIDU, and Celldex Released By InvestorsObserver 10:31 a.m. Jan. 9, 2014 - PR Newswire
Retirement Announcements, Stock Price Movements, and Scheduled Conferences Presentations - Research Report on Gilead, Aegerion, Celldex, Alnylam, and Ironwood 9:00 a.m. Jan. 9, 2014 - PR Newswire
Clinical Study Updates, Collaborations, and Stock Price Updates - Research Report on Medtronic, Regeneron, Celldex, Cubist, and MannKind 9:00 a.m. Dec. 31, 2013 - PR Newswire
Health Care Sector Technical Data: XOMA, Celldex Therapeutics, Illumina, and Immunomedics 9:12 a.m. Dec. 19, 2013 - PR Newswire
Share Price Movements and Clinical Studies - Research Report on Celldex Therapeutics, Envision, MannKind, Covance, and Auxilium 9:00 a.m. Dec. 19, 2013 - PR Newswire
Clinical Trial Results, Partnerships, and Reimbursement Rates - Research Report on Celldex, Centene, Enanta, Novartis, and BG Medicine 9:00 a.m. Dec. 13, 2013 - PR Newswire
New Clinical Trials, Pricing of Common Stock and Adjusted Conversion of Convertible Senior Notes - Research Report on Regeneron, Celldex, PDL BioPharma, Amedisys, and Exelixis 9:00 a.m. Dec. 11, 2013 - PR Newswire
Celldex's CDX-301 in Combination with Mozobil(R) Increases Hematopoietic Stem Cell Mobilization and Results in Improved Transplantation of Mobilized Cells in Preclinical Studies; Results Presented at ASH 2013 9:30 a.m. Dec. 10, 2013 - GlobeNewswire
Celldex Announces Exercise of Underwriters' Option to Purchase Additional Shares 6:03 p.m. Dec. 9, 2013 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼